Impact of Participant Characteristics on Clinical Outcomes with iGlarLixi in Type 2 Diabetes: Post Hoc Analysis of SPARTA Japan.

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2024)

UMIN-CTR Trials Registry, UMIN000044126; registered 10 May 2021.

Keyphrases